img

Global Submucosal Injection Agent Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Submucosal Injection Agent Market Research Report 2024

The global Submucosal Injection Agent market was valued at US$ 97.43 million in 2024 and is anticipated to reach US$ 163.51 million by 2034, witnessing a CAGR of 7.67% during the forecast period 2024-2034. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Submucosal Injection Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injection Agent.
The Submucosal Injection Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2018 to 2024. This report segments the global Submucosal Injection Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injection Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.




By Company


Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Segment by Type
Syringe Type
Ampoule Type


Segment by Application


Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Consumption by Region


North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific

Europe
Germany
UK
France
Russia
Italy
Spain
Rest of Europe

Latin America
Brazil
Argentina
Colombia
Rest of Latin America

Table of Content

1 Submucosal Injection Agent Market Overview 1
1.1 Product Definition 1
1.2 Submucosal Injection Agent by Type 1
1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2024-2034) 2
1.2.2 Syringe Type 3
1.2.3 Ampoule Type 3
1.3 Submucosal Injection Agent by Application 4
1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts 6
1.4.1 Global Submucosal Injection Agent Revenue 2018-2034 6
1.4.2 Global Submucosal Injection Agent Sales 2018-2034 8
1.5 Assumptions and Limitations 8
2 Submucosal Injection Agent Market Competition by Manufacturers 10
2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 10
2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2023) 12
2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2023) 14
2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2024 VS 2023 14
2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15
2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type 15
2.7 Global Submucosal Injection Agent Market Competitive Situation and Trends 16
2.7.1 Global Submucosal Injection Agent Market Concentration Rate 16
2.7.2 The Global 3 and 5 Largest Submucosal Injection Agent Players Market Share by Revenue 17
2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18
3 Global Submucosal Injection Agent Market Scenario by Region 19
3.1 Global Submucosal Injection Agent Market Size by Region: 2018 Versus 2024 Versus 2034 19
3.2 Global Submucosal Injection Agent Sales by Region: 2018-2034 20
3.2.1 Global Submucosal Injection Agent Sales by Region: 2018-2023 20
3.2.2 Global Submucosal Injection Agent Sales by Region: 2024-2034 20
3.3 Global Submucosal Injection Agent Revenue by Region: 2018-2034 21
3.3.1 Global Submucosal Injection Agent Revenue by Region: 2018-2023 21
3.3.2 Global Submucosal Injection Agent Revenue by Region: 2024-2034 22
3.4 North America Submucosal Injection Agent Market Facts & Figures by Country 22
3.4.1 North America Submucosal Injection Agent Sales by Country (2018-2034) 22
3.4.2 North America Submucosal Injection Agent Revenue by Country (2018-2034) 23
3.4.3 United States 25
3.4.4 Canada 25
3.4.5 Mexico 26
3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country 26
3.5.1 Europe Submucosal Injection Agent Sales by Country (2018-2034) 26
3.5.2 Europe Submucosal Injection Agent Revenue by Country (2018-2034) 27
3.5.3 Germany 29
3.5.4 France 29
3.5.5 U.K. 30
3.5.6 Italy 30
3.5.7 Russia 31
3.5.8 Spain 31
3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region 32
3.6.1 Asia Pacific Submucosal Injection Agent Sales by Region (2018-2034) 32
3.6.2 Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2034) 33
3.6.3 China 35
3.6.4 Japan 35
3.6.5 South Korea 36
3.6.6 India 36
3.6.7 Australia 37
3.6.8 Southeast Asia 37
3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country 38
3.7.1 Latin America Submucosal Injection Agent Sales by Country (2018-2034) 38
3.7.2 Latin America Submucosal Injection Agent Revenue by Country 39
3.7.3 Brazil 40
3.7.4 Argentina 41
3.7.5 Colombia 41
3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country 42
3.8.1 Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2034) 42
3.8.2 Middle East and Africa Submucosal Injection Agent Revenue by Country 43
3.8.3 Middle East 44
3.8.4 Africa 45
4 Segment by Type 46
4.1 Global Submucosal Injection Agent Sales by Type (2018-2034) 46
4.1.1 Global Submucosal Injection Agent Sales by Type (2018-2023) 46
4.1.2 Global Submucosal Injection Agent Sales by Type (2024-2034) 46
4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2018-2034) 46
4.2 Global Submucosal Injection Agent Revenue by Type (2018-2034) 47
4.2.1 Global Submucosal Injection Agent Revenue by Type (2018-2023) 47
4.2.2 Global Submucosal Injection Agent Revenue by Type (2024-2034) 47
4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2018-2034) 48
4.3 Global Submucosal Injection Agent Price by Type (2018-2034) 49
5 Segment by Application 50
5.1 Global Submucosal Injection Agent Sales by Application (2018-2034) 50
5.1.1 Global Submucosal Injection Agent Sales by Application (2018-2023) 50
5.1.2 Global Submucosal Injection Agent Sales by Application (2024-2034) 50
5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2018-2034) 50
5.2 Global Submucosal Injection Agent Revenue by Application (2018-2034) 51
5.2.1 Global Submucosal Injection Agent Revenue by Application (2018-2023) 51
5.2.2 Global Submucosal Injection Agent Revenue by Application (2024-2034) 52
5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2018-2034) 52
5.3 Global Submucosal Injection Agent Price by Application (2018-2034) 53
6 Key Companies Profiled 54
6.1 Seikagaku 54
6.1.1 Seikagaku Corporation Information 54
6.1.2 Seikagaku Introduction and Business Overview 54
6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 54
6.1.4 Seikagaku Submucosal Injection Agent Products Offered 55
6.2 Ovesco Endoscopy 55
6.2.1 Ovesco Endoscopy Corporation Information 55
6.2.2 Ovesco Endoscopy Introduction and Business Overview 56
6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 56
6.2.4 Ovesco Endoscopy Submucosal Injection Agent Products Offered 56
6.3 GI Supply 57
6.3.1 GI Supply Corporation Information 57
6.3.2 GI Supply Introduction and Business Overview 58
6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 58
6.3.4 GI Supply Submucosal Injection Agent Products Offered 58
6.4 Cosmo Pharmaceuticals 59
6.4.1 Cosmo Pharmaceuticals Corporation Information 59
6.4.2 Cosmo Pharmaceuticals Introduction and Business Overview 59
6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 60
6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Products Offered 60
6.5 Boston Scientific 61
6.5.1 Boston Scientific Corporation Information 61
6.5.2 Boston Scientific Introduction and Business Overview 61
6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 61
6.5.4 Boston Scientific Submucosal Injection Agent Products Offered 62
6.6 The Standard 62
6.6.1 The Standard Corporation Information 62
6.6.2 The Standard Introduction and Business Overview 63
6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 63
6.6.4 The Standard Submucosal Injection Agent Products Offered 63
6.7 Micro-Tech Endoscopy 64
6.7.1 Micro-Tech Endoscopy Corporation Information 64
6.7.2 Micro-Tech Endoscopy Introduction and Business Overview 64
6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 65
6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Products Offered 65
6.8 EndoClot Plus 66
6.8.1 EndoClot Plus Corporation Information 66
6.8.2 EndoClot Plus Introduction and Business Overview 66
6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 67
6.8.4 EndoClot Plus Submucosal Injection Agent Products Offered 67
7 Industry Chain and Sales Channels Analysis 68
7.1 Submucosal Injection Agent Industry Chain Analysis 68
7.2 Submucosal Injection Agent Key Raw Materials 68
7.2.1 Key Raw Materials 68
7.2.2 Raw Materials Key Suppliers 70
7.2.3 Raw Materials 70
7.2.4 Labor Cost 71
7.2.5 Manufacturing Expenses 71
7.3 Submucosal Injection Agent Sales and Marketing 71
7.3.1 Submucosal Injection Agent Distributors 71
7.4 Submucosal Injection Agent Customers 72
8 Submucosal Injection Agent Market Dynamics 74
8.1 Submucosal Injection Agent Industry Trends 74
8.2 Submucosal Injection Agent Market Drivers 74
8.3 Submucosal Injection Agent Market Challenges 75
9 Research Findings and Conclusion 76
10 Methodology and Data Source 77
10.1 Methodology/Research Approach 77
10.1.1 Research Programs/Design 77
10.1.2 Market Size Estimation 77
10.1.3 Market Breakdown and Data Triangulation 79
10.2 Data Source 80
10.2.1 Secondary Sources 80
10.2.2 Primary Sources 81
10.3 Author List 83
10.4 Disclaimer 85

List of Figure

Table 1. Global Submucosal Injection Agent Market Value Comparison by Type (2024-2034) & (US$ Million) 2
Table 2. Global Submucosal Injection Agent Market Value by Application (2024-2034) & (US$ Million) 4
Table 3. Global Submucosal Injection Agent Market Competitive Situation by Manufacturers in 2024 10
Table 4. Global Submucosal Injection Agent Sales (K Units) of Key Manufacturers (2020-2023) 11
Table 5. Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 11
Table 6. Global Submucosal Injection Agent Revenue (US$ Million) by Manufacturers (2020-2023) 12
Table 7. Global Submucosal Injection Agent Revenue Share by Manufacturers (2020-2023) 13
Table 8. Global Market Submucosal Injection Agent Average Price (US$/Unit) of Key Manufacturers (2020-2023) 14
Table 9. Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2024 VS 2023 14
Table 10. Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15
Table 11. Global Key Manufacturers of Submucosal Injection Agent, Product Type 15
Table 12. Global Manufacturers Market Concentration Ratio (CR5) 16
Table 13. Global Submucosal Injection Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Injection Agent as of 2024) 18
Table 14. Global Submucosal Injection Agent Market Size by Region (US$ Million): 2018 VS 2024 VS 2034 19
Table 15. Global Submucosal Injection Agent Sales by Region (2018-2023) & (K Units) 20
Table 16. Global Submucosal Injection Agent Sales Market Share by Region (2018-2023) 20
Table 17. Global Submucosal Injection Agent Sales by Region (2024-2034) & (K Units) 20
Table 18. Global Submucosal Injection Agent Sales Market Share by Region (2024-2034) 21
Table 19. Global Submucosal Injection Agent Revenue by Region (2018-2023) & (US$ Million) 21
Table 20. Global Submucosal Injection Agent Revenue Market Share by Region (2018-2023) 21
Table 21. Global Submucosal Injection Agent Revenue by Region (2024-2034) & (US$ Million) 22
Table 22. Global Submucosal Injection Agent Revenue Market Share by Region (2024-2034) 22
Table 23. North America Submucosal Injection Agent Sales by Country (2018-2023) & (K Units) 22
Table 24. North America Submucosal Injection Agent Sales by Country (2024-2034) & (K Units) 23
Table 25. North America Submucosal Injection Agent Revenue by Country (2018-2023) & (US$ Million) 23
Table 26. North America Submucosal Injection Agent Revenue by Country (2024-2034) & (US$ Million) 24
Table 27. Europe Submucosal Injection Agent Sales by Country (2018-2023) & (K Units) 26
Table 28. Europe Submucosal Injection Agent Sales by Country (2024-2034) & (K Units) 27
Table 29. Europe Submucosal Injection Agent Revenue by Country (2018-2023) & (US$ Million) 27
Table 30. Europe Submucosal Injection Agent Revenue by Country (2024-2034) & (US$ Million) 28
Table 31. Asia Pacific Submucosal Injection Agent Sales by Region (2018-2023) & (K Units) 32
Table 32. Asia Pacific Submucosal Injection Agent Sales by Region (2024-2034) & (K Units) 32
Table 33. Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2023) & (US$ Million) 33
Table 34. Asia Pacific Submucosal Injection Agent Revenue by Region (2024-2034) & (US$ Million) 33
Table 35. Latin America Submucosal Injection Agent Sales by Country (2018-2023) & (K Units) 38
Table 36. Latin America Submucosal Injection Agent Sales by Country (2024-2034) & (K Units) 38
Table 37. Latin America Submucosal Injection Agent Revenue by Country (2018-2023) & (US$ Million) 39
Table 38. Latin America Submucosal Injection Agent Revenue by Region (2024-2034) & (US$ Million) 39
Table 39. Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2023) & (K Units) 42
Table 40. Middle East and Africa Submucosal Injection Agent Sales by Country (2024-2034) & (K Units) 42
Table 41. Middle East and Africa Submucosal Injection Agent Revenue by Country (2018-2023) & (US$ Million) 43
Table 42. Middle East and Africa Submucosal Injection Agent Revenue by Country (2024-2034) & (US$ Million) 43
Table 43. Global Submucosal Injection Agent Sales (K Units) by Type (2018-2023) 46
Table 44. Global Submucosal Injection Agent Sales (K Units) by Type (2024-2034) 46
Table 45. Global Submucosal Injection Agent Sales Market Share by Type (2018-2023) 46
Table 46. Global Submucosal Injection Agent Sales Market Share by Type (2024-2034) 46
Table 47. Global Submucosal Injection Agent Revenue (US$ Million) by Type (2018-2023) 47
Table 48. Global Submucosal Injection Agent Revenue (US$ Million) by Type (2024-2034) 47
Table 49. Global Submucosal Injection Agent Revenue Market Share by Type (2018-2023) 48
Table 50. Global Submucosal Injection Agent Revenue Market Share by Type (2024-2034) 48
Table 51. Global Submucosal Injection Agent Price (US$/Unit) by Type (2018-2023) 49
Table 52. Global Submucosal Injection Agent Price (US$/Unit) by Type (2024-2034) 49
Table 53. Global Submucosal Injection Agent Sales (K Units) by Application (2018-2023) 50
Table 54. Global Submucosal Injection Agent Sales (K Units) by Application (2024-2034) 50
Table 55. Global Submucosal Injection Agent Sales Market Share by Application (2018-2023) 50
Table 56. Global Submucosal Injection Agent Sales Market Share by Application (2024-2034) 51
Table 57. Global Submucosal Injection Agent Revenue (US$ Million) by Application (2018-2023) 51
Table 58. Global Submucosal Injection Agent Revenue (US$ Million) by Application (2024-2034) 52
Table 59. Global Submucosal Injection Agent Revenue Market Share by Application (2018-2023) 52
Table 60. Global Submucosal Injection Agent Revenue Market Share by Application (2024-2034) 52
Table 61. Global Submucosal Injection Agent Price (US$/Unit) by Application (2018-2023) 53
Table 62. Global Submucosal Injection Agent Price (US$/Unit) by Application (2024-2034) 53
Table 63. Seikagaku Corporation Information 54
Table 64. Seikagaku Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 54
Table 65. Seikagaku Submucosal Injection Agent Product 55
Table 66. Ovesco Endoscopy Corporation Information 55
Table 67. Ovesco Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 56
Table 68. Ovesco Endoscopy Submucosal Injection Agent Product 56
Table 69. GI Supply Corporation Information 57
Table 70. GI Supply Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 58
Table 71. GI Supply Submucosal Injection Agent Product 58
Table 72. Cosmo Pharmaceuticals Corporation Information 59
Table 73. Cosmo Pharmaceuticals Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 60
Table 74. Cosmo Pharmaceuticals Submucosal Injection Agent Product 60
Table 75. Boston Scientific Corporation Information 61
Table 76. Boston Scientific Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 61
Table 77. Boston Scientific Submucosal Injection Agent Product 62
Table 78. The Standard Corporation Information 62
Table 79. The Standard Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 63
Table 80. The Standard Submucosal Injection Agent Product 63
Table 81. Micro-Tech Endoscopy Corporation Information 64
Table 82. Micro-Tech Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 65
Table 83. Micro-Tech Endoscopy Submucosal Injection Agent Product 65
Table 84. EndoClot Plus Corporation Information 66
Table 85. EndoClot Plus Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2023) 67
Table 86. EndoClot Plus Submucosal Injection Agent Product 67
Table 87. Raw Materials Key Suppliers Lists 70
Table 88. Submucosal Injection Agent Distributors List 71
Table 89. Submucosal Injection Agent Customers List 72
Table 90. Submucosal Injection Agent Market Trends 74
Table 91. Submucosal Injection Agent Market Challenges 75
Table 92. Research Programs/Design for This Report 77
Table 93. Key Data Information from Secondary Sources 81
Table 94. Key Data Information from Primary Sources 82
Table 95. Authors List of This Report 83
Table 96. QYR Business Unit and Senior & Team Lead Analysts 83



List of Figures

Figure 1. Product Picture of Submucosal Injection Agent 1
Figure 2. Global Submucosal Injection Agent Market Value Comparison by Type (2024-2034) & (US$ Million) 2
Figure 3. Global Submucosal Injection Agent Market Share by Type: 2024 & 2034 3
Figure 4. Syringe Type Product Picture 3
Figure 5. Ampoule Type Product Picture 4
Figure 6. Global Submucosal Injection Agent Market Value by Application (2024-2034) & (US$ Million) 5
Figure 7. Global Submucosal Injection Agent Market Share by Application: 2024 & 2034 6
Figure 8. Global Submucosal Injection Agent Revenue, (US$ Million), 2018 VS 2024 VS 2034 7
Figure 9. Global Submucosal Injection Agent Market Size (2018-2034) & (US$ Million) 7
Figure 10. Global Submucosal Injection Agent Sales (2018-2034) & (K Units) 8
Figure 11. Submucosal Injection Agent Report Years Considered 9
Figure 12. Submucosal Injection Agent Sales Share by Manufacturers in 2024 12
Figure 13. Global Submucosal Injection Agent Revenue Share by Manufacturers in 2024 13
Figure 14. Global 3 Largest Submucosal Injection Agent Players: Market Share by Revenue in Submucosal Injection Agent in 2024 17
Figure 15. Global 5 Largest Submucosal Injection Agent Players: Market Share by Revenue in Submucosal Injection Agent in 2024 17
Figure 16. North America Submucosal Injection Agent Sales Market Share by Country (2018-2023) 23
Figure 17. North America Submucosal Injection Agent Revenue Market Share by Country (2018-2023) 24
Figure 18. United States Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 25
Figure 19. Canada Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 25
Figure 20. Mexico Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 26
Figure 21. Europe Submucosal Injection Agent Sales Market Share by Country (2018-2023) 27
Figure 22. Europe Submucosal Injection Agent Revenue Market Share by Country (2018-2023) 28
Figure 23. Germany Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 29
Figure 24. France Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 29
Figure 25. U.K. Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 30
Figure 26. Italy Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 30
Figure 27. Russia Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 31
Figure 28. Spain Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 31
Figure 29. Asia Pacific Submucosal Injection Agent Sales Market Share by Region (2018-2023) 33
Figure 30. Asia Pacific Submucosal Injection Agent Revenue Market Share by Region (2018-2023) 34
Figure 31. China Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 35
Figure 32. Japan Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 35
Figure 33. South Korea Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 36
Figure 34. India Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 36
Figure 35. Australia Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 37
Figure 36. Southeast Asia Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 37
Figure 37. Latin America Submucosal Injection Agent Sales Market Share by Country (2018-2023) 39
Figure 38. Latin America Submucosal Injection Agent Revenue Market Share by Region (2018-2023) 40
Figure 39. Brazil Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 40
Figure 40. Argentina Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 41
Figure 41. Colombia Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 41
Figure 42. Middle East and Africa Submucosal Injection Agent Sales Market Share by Country (2018-2023) 43
Figure 43. Middle East and Africa Submucosal Injection Agent Revenue Market Share by Country (2018-2023) 44
Figure 44. Middle East Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 44
Figure 45. Africa Submucosal Injection Agent Revenue Growth Rate (2018-2034) & (US$ Million) 45
Figure 46. Global Sales Market Share of Submucosal Injection Agent by Type (2018-2023) 47
Figure 47. Global Revenue Market Share of Submucosal Injection Agent by Type (2018-2023) 48
Figure 48. Global Sales Market Share of Submucosal Injection Agent by Application (2018-2023) 51
Figure 49. Global Revenue Market Share of Submucosal Injection Agent by Application (2018-2023) 53
Figure 50. Submucosal Injection Agent Value Chain 68
Figure 51. Submucosal Injection Agent Manufacturing Cost Structure 70
Figure 52. Distributors Profiles 72
Figure 53. Bottom-up and Top-down Approaches for This Report 79
Figure 54. Data Triangulation 80
Figure 55. Key Executives Interviewed 82